Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein kinase inhibitors for cancer, cardiovascular disorders discovered at Vertex

Oct. 1, 2001

MMP inhibitor developed at Banyu induces apoptosis in human leukemia cells

Oct. 1, 2001

First NDA filing for PhotoCure in U.S.

Oct. 1, 2001

Selective cdk2 inhibitor induces apoptosis, inhibits proliferation in human tumor cells

Oct. 1, 2001

Atrix submits NDA for Leuprogel Three-Month Depot for prostate cancer

Sep. 28, 2001

Development candidate selected by GSK from Cytokinetics' second-generation antimitotics

Sep. 27, 2001

Phase II trial assessing Angiozyme in combination with chemotherapy initiated

Sep. 27, 2001

Enrollment completed for phase IIa trial of repifermin for mucositis

Sep. 27, 2001

First trial of thioredoxin inhibitor initiated in cancer patients

Sep. 27, 2001

Pharmacological interaction of irofulven and docetaxel under study

Sep. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...